-
2
-
-
0020693079
-
Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding
-
Pinnick RV, Wiegmann TB, Diederich DA (1983) Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 308:258-261
-
(1983)
N Engl J Med
, vol.308
, pp. 258-261
-
-
Pinnick, R.V.1
Wiegmann, T.B.2
Diederich, D.A.3
-
3
-
-
0025089550
-
Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients
-
Mehta R, McDonald B, Aguilar M, Ward DM (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976-981
-
(1990)
Kidney Int
, vol.38
, pp. 976-981
-
-
Mehta, R.1
McDonald, B.2
Aguilar, M.3
Ward, D.M.4
-
4
-
-
38849176333
-
Regional citrate anticoagulation for single-needle hemodialysis: A prospective clinical study
-
Gubensek J, Buturovic-Ponikvar J, Ponikvar R (2007) Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study. Blood Purif 25:454-456
-
(2007)
Blood Purif
, vol.25
, pp. 454-456
-
-
Gubensek, J.1
Buturovic-Ponikvar, J.2
Ponikvar, R.3
-
5
-
-
35748963862
-
Efficacy and safety of intermittent hemodialysis using citrate as anticoagulant: A prospective study
-
Schneider M, Thomas K, Liefeldt L, Kindgen-Milles D, Peters H, Neumayer HH, Morgera S (2007) Efficacy and safety of intermittent hemodialysis using citrate as anticoagulant: a prospective study. Clin Nephrol 68:302-307
-
(2007)
Clin Nephrol
, vol.68
, pp. 302-307
-
-
Schneider, M.1
Thomas, K.2
Liefeldt, L.3
Kindgen-Milles, D.4
Peters, H.5
Neumayer, H.H.6
Morgera, S.7
-
6
-
-
0036944359
-
Pediatric hemofiltration. Normocarb dialysate solution with citrate anticoagulation
-
Bunchman TE, Maxvold NJ, Barnett J, Hutchings A, Benfield MR (2002) Pediatric hemofiltration. Normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol 17:150-154
-
(2002)
Pediatr Nephrol
, vol.17
, pp. 150-154
-
-
Bunchman, T.E.1
Maxvold, N.J.2
Barnett, J.3
Hutchings, A.4
Benfield, M.R.5
-
7
-
-
0344826831
-
Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation
-
Bunchman TE, Maxvold NJ, Brophy PD (2003) Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 42:1248-1252
-
(2003)
Am J Kidney Dis
, vol.42
, pp. 1248-1252
-
-
Bunchman, T.E.1
Maxvold, N.J.2
Brophy, P.D.3
-
8
-
-
0036947439
-
Citrate clearance in children receiving continuous venovenous renal replacement therapy
-
Chadha V, Garg U, Warady BA, Alon US (2002) Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 17:819-824
-
(2002)
Pediatr Nephrol
, vol.17
, pp. 819-824
-
-
Chadha, V.1
Garg, U.2
Warady, B.A.3
Alon, U.S.4
-
9
-
-
0842323883
-
Citrate anticoagulation in pediatric continuous venovenous hemofiltration
-
Elhanan N, Skippen P, Nuthall G, Krahn G, Seear M (2004) Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol 19:208-212
-
(2004)
Pediatr Nephrol
, vol.19
, pp. 208-212
-
-
Elhanan, N.1
Skippen, P.2
Nuthall, G.3
Krahn, G.4
Seear, M.5
-
10
-
-
34548836853
-
Demographic characteristics of pediatric continuous renal replacement therapy: A report of the prospective pediatric continuous renal replacement therapy registry
-
Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL (2007) Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2:732-738
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, pp. 732-738
-
-
Symons, J.M.1
Chua, A.N.2
Somers, M.J.3
Baum, M.A.4
Bunchman, T.E.5
Benfield, M.R.6
Brophy, P.D.7
Blowey, D.8
Fortenberry, J.D.9
Chand, D.10
Flores, F.X.11
Hackbarth, R.12
Alexander, S.R.13
Mahan, J.14
McBryde, K.D.15
Goldstein, S.L.16
-
11
-
-
0030933750
-
The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit
-
Ward DM (1997) The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit. Adv Ren Replace Ther 4:160-173
-
(1997)
Adv Ren Replace Ther
, vol.4
, pp. 160-173
-
-
Ward, D.M.1
-
13
-
-
0034824516
-
Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation
-
Calatzis A, Toepfer M, Schramm W, Spannagl M, Schiffl H (2001) Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron 89:233-236
-
(2001)
Nephron
, vol.89
, pp. 233-236
-
-
Calatzis, A.1
Toepfer, M.2
Schramm, W.3
Spannagl, M.4
Schiffl, H.5
-
14
-
-
0014004037
-
Activated coagulation time of whole blood
-
Hattersley PG (1966) Activated coagulation time of whole blood. JAMA 196:436-440
-
(1966)
JAMA
, vol.196
, pp. 436-440
-
-
Hattersley, P.G.1
-
15
-
-
52149114450
-
Perioperative coagulation management and blood conservation in cardiac surgery: A Canadian survey
-
Taneja R, Fernandes P, Marwaha G, Cheng D, Bainbridge D (2008) Perioperative coagulation management and blood conservation in cardiac surgery: a Canadian Survey. J Cardiothorac Vasc Anesth 22:662-669
-
(2008)
J Cardiothorac Vasc Anesth
, vol.22
, pp. 662-669
-
-
Taneja, R.1
Fernandes, P.2
Marwaha, G.3
Cheng, D.4
Bainbridge, D.5
-
16
-
-
38849159222
-
A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass
-
Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS (2008) A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 22:47-52
-
(2008)
J Cardiothorac Vasc Anesth
, vol.22
, pp. 47-52
-
-
Slight, R.D.1
Buell, R.2
Nzewi, O.C.3
McClelland, D.B.4
Mankad, P.S.5
-
17
-
-
0029934065
-
The activated coagulation time: Suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery
-
Martindale SJ, Shayevitz JR, D'Errico C (1996) The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery. J Cardiothorac Vasc Anesth 10:458-463
-
(1996)
J Cardiothorac Vasc Anesth
, vol.10
, pp. 458-463
-
-
Martindale, S.J.1
Shayevitz, J.R.2
D'Errico, C.3
-
18
-
-
0015065072
-
The activated coagulation time of whole blood as a routine pre-operative sceening test
-
Hattersley PG (1971) The activated coagulation time of whole blood as a routine pre-operative sceening test. Calif Med 114:15-18
-
(1971)
Calif Med
, vol.114
, pp. 15-18
-
-
Hattersley, P.G.1
-
19
-
-
0034792364
-
Activated clotting time as a screening test prior to catheter-based cardiovascular procedures
-
Siskin GP, Reiner E, Stainken BF, Dowling K, Dolen EG, Quarfordt S, Albons G (2001) Activated clotting time as a screening test prior to catheter-based cardiovascular procedures. Catheter Cardiovasc Interv 54:191-195
-
(2001)
Catheter Cardiovasc Interv
, vol.54
, pp. 191-195
-
-
Siskin, G.P.1
Reiner, E.2
Stainken, B.F.3
Dowling, K.4
Dolen, E.G.5
Quarfordt, S.6
Albons, G.7
-
20
-
-
77954542561
-
Anticoagulation options for pediatric hemodialysis
-
Davenport A (2003) Anticoagulation options for pediatric hemodialysis. Hemodial Int 7:168-176
-
(2003)
Hemodial Int
, vol.7
, pp. 168-176
-
-
Davenport, A.1
-
21
-
-
52149091971
-
An unusual cause of a prolonged activated coagulation time during cardiac surgery: Congenital hypofibrinogenemia
-
Rani TR, Gopinath R (2008) An unusual cause of a prolonged activated coagulation time during cardiac surgery: congenital hypofibrinogenemia. J Cardiothorac Vasc Anesth 22:725-726
-
(2008)
J Cardiothorac Vasc Anesth
, vol.22
, pp. 725-726
-
-
Rani, T.R.1
Gopinath, R.2
-
22
-
-
0031693646
-
How does warfarin affect the activated coagulation time?
-
Chang RJ, Doherty TM, Goldberg SL (1998) How does warfarin affect the activated coagulation time? Am Heart J 136:477-479
-
(1998)
Am Heart J
, vol.136
, pp. 477-479
-
-
Chang, R.J.1
Doherty, T.M.2
Goldberg, S.L.3
-
23
-
-
0029441639
-
Influence of coagulation parameters on filter running time during continuous venovenous hemofiltration
-
Stefanidis I, Hägel J, Maurin N (1995) Influence of coagulation parameters on filter running time during continuous venovenous hemofiltration. Contrib Nephrol 116:145-149
-
(1995)
Contrib Nephrol
, vol.116
, pp. 145-149
-
-
Stefanidis, I.1
Hägel, J.2
Maurin, N.3
-
24
-
-
0036210868
-
Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center
-
Lord H, Jean N, Dumont M, Kassis J, Leblanc M (2002) Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center. Am J Nephrol 22:58-66
-
(2002)
Am J Nephrol
, vol.22
, pp. 58-66
-
-
Lord, H.1
Jean, N.2
Dumont, M.3
Kassis, J.4
Leblanc, M.5
-
25
-
-
33646373411
-
Thrombocytopathy and bleeding complications in Uremia
-
Hörl WH (2006) Thrombocytopathy and bleeding complications in Uremia. Wien Klin Wochenschr 118:134-150
-
(2006)
Wien Klin Wochenschr
, vol.118
, pp. 134-150
-
-
Hörl, W.H.1
-
26
-
-
0036218363
-
Citrate anticoagulation in a piglet model of pediatric continuous renal replacement therapy
-
Nuthall G, Skippen P, Daoust C, Al-Jofan F, Seear M (2002) Citrate anticoagulation in a piglet model of pediatric continuous renal replacement therapy. Crit Care Med 30:900-903
-
(2002)
Crit Care Med
, vol.30
, pp. 900-903
-
-
Nuthall, G.1
Skippen, P.2
Daoust, C.3
Al-Jofan, F.4
Seear, M.5
-
27
-
-
33746608575
-
Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous hemofiltration: Use of ionized and total/ionized calcium
-
Bakker AJ, Boerma EC, Keidel H, Kingma P, Van Der Voort PH (2006) Detection of citrate overdose in critically ill patients on citrate- anticoagulated venovenous hemofiltration: use of ionized and total/ionized calcium. Clin Chem Lab Med 44:962-966
-
(2006)
Clin Chem Lab Med
, vol.44
, pp. 962-966
-
-
Bakker, A.J.1
Boerma, E.C.2
Keidel, H.3
Kingma, P.4
Van Der Voort, P.H.5
-
28
-
-
33847673290
-
Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis
-
Opatrný K, Richtrová P, Polanská K, Wirth J, Sefrna F, Brandl M, Falkenhagen D (2007) Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis. Artif Organs 31:200-207
-
(2007)
Artif Organs
, vol.31
, pp. 200-207
-
-
Opatrný, K.1
Richtrová, P.2
Polanská, K.3
Wirth, J.4
Sefrna, F.5
Brandl, M.6
Falkenhagen, D.7
-
29
-
-
62149125881
-
New equations to estimate GFR in children with CKD
-
Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629-637
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 629-637
-
-
Schwartz, G.J.1
Muñoz, A.2
Schneider, M.F.3
Mak, R.H.4
Kaskel, F.5
Warady, B.A.6
Furth, S.L.7
|